Akari Therapeutics Plc (AKTX)
4.47
-0.18
(-3.87%)
USD |
NASDAQ |
Apr 02, 16:00
4.19
-0.28
(-6.26%)
After-Hours: 20:00
Akari Therapeutics Market Cap : 5.116M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| DBV Technologies SA | 1.191B |
| Cellectis SA | 354.18M |
| Biodexa Pharmaceuticals Plc | 14.15M |
| Mereo BioPharma Group Plc | 49.34M |
| Bicycle Therapeutics Plc | 363.51M |
Market Cap Related Metrics
| PEG Ratio | -0.0005 |
| Price to Book Value | 0.1806 |
| Price | 4.47 |
| Earnings Yield | -231.8% |
| PEGY Ratio | -0.0005 |